Oct 2, 2024 4:05pm EDT Processa Pharmaceuticals Announces First Patient Dosed in Phase 2 Clinical Trial of NGC-Cap in Metastatic Breast Cancer
Sep 3, 2024 8:00am EDT Processa Pharmaceuticals to Participate in Investor and Industry Conferences During September